Association of increased CD4+T-cell infiltration with increased IL-16 gene expression in atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 4 II, 1998, Pages 645-650

  Laberge, Sophie ^a,b   Ghaffar, Omar ^a   Boguniewicz, Mark ^c   Center, David M ^d   Leung, Donald Y ^c   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic inflammation; Atopic dermatitis; Chemotaxis; IL I6

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 16; MESSENGER RNA;

ACUTE DISEASE; ARTICLE; ATOPIC DERMATITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; SKIN INFLAMMATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0031768650     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70282-9     Document Type: Article

References (32)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-18.
2. Su JC, Kemp AS, Varigos GA, Nolan TM. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997;76:159-62.
3. Leung DYM, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71:47-56.
4. Zachary CB, Allen MH, MacDonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic dermatitis. Br J Derm 1985;112:149-56.
5. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
6. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, et al. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154:1956-63.
7. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DYM. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
8. Munro CS, Higgins EM, Marks JM, Daly BM, Friedmann PS, Shuster S. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions. Br J Dermatol 1991;124:43-8.
9. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-40.
10. van Joost TH, Kozel MMA, Tank B, Troost R, Prens EP. Cyclosporin in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol 1992;27:922-8.
11. Berman JS, Beer DJ, Cruikshank WW, Center DM. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol 1985;95:105-12.
12. Cruikshank WW, Center DM, Nisar N, Wu M, Natke B, Theodore AC, et al. Molecular and functional analysis of a lymphocyte chemo at tractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 1994;91:5109-13.
13. Center DM, Kornfeld H, Cruikshank WW. Interleukin-16 and its function as a CD4 ligand. Immunol Today 1996;17:476-81.
14. Lim KG, Wan HC, Bozza PT, Resnik MB, Wong DTW, Cruikshank WW, et al. Human eosinophils elaborates the lymphocyte chemoattractants: IL-16 (Lymphocyte chemo at tract ant factor) and RANTES. J Immunol 1996;156:2566-70.
15. Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997;159:2904-10.
16. Arima M, Plitt JR, Stellano C, Schwiebert LM, Schleimer RP. The expression of lymphocyte chemoattractant factor (LCF) in human bronchial epithelial cells [abstract]. J Allergy Clin Immunol 1996;97:S443.
17. Laberge S, Ernst P, Ghaffar O, Cruinkshank WW, Center DM, Hamid Q. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol 1997:17:193-202.
18. Cruikshank WW, Long A, Tarpy R, Kornfeld H, Carroll MP, Teran L, et al. Early identification of lymphocyte chemoattractant factor (PL-16) and macrophage inflammatory protein-let in BAL of antigen challenged asthmatics. Am J Respir Cell Mol Biol 1995:13:738-47.
19. Laberge S, Durham SR, Ghaffar O, Rak S, Center DM, Jacobson M, et al. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticoid treatment. J Allergy Clin Immunol 1997:100:569-74.
20. Hanifin JM. Atopic dermatitis. J Allergy Clin Immunol 1984:73:211-22.
21. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, et al. Induction of nitric oxide synthase in asthma. Lancet 1993:342:1510-3.
22. Ying S, Durham SR, Jacobson MR, Rak S, Masuyama K, Lowhagen O, et al. T lymphocytes and mast cells express messenger RNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994:82:200-6.
23. +) in both normal and diseased human skin. Arch Dermatol Res 1989;281:24-30.
24. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-8.
25. Schleimer RP, Hamid Q. Regulation of allergic airways inflammation by cytokines and glucocorticoids. In: Lichtenstein LM, Austen F, Kay AB, Holgate S, Marone G, editors. Asthma V. Asthma and allergic diseases: physiology, immunopharmacology and treatment. London: Academic Press; 1998. p. 337-55.
26. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994;30:535-46.
27. Li J, Ireland GW, Farthing PM, Thornhill MH. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996;106:661-6.
28. Won Y-H, Sauder DN, McKenzie RC. Cyclosporin A inhibits keratinocyte cytokine gene expression. Br J Dermatol 1994;130:312-9.
29. Aragame Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, et al. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 1994;153:5366-72.
30. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J Clin Invest 1997;99:3009-12.
31. Laberge S, Durham SR, Ghaffar O, Rak S, Center DM, Jacobson M, et al. Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 1997;100:569-74.
32. Laberge S, Ghaffar O, Ernst P, Olivenstein R, Center DM, Hamid Q. Phenotype of IL-16-producing cells in atopic asthma [abstract], J Allergy Clin Immunol 1998;101:S235.